A few days after the authorization of the Russian vaccine by its health authorities, Hungary announced to buy “large quantities”. Viktor Orban took the opportunity to criticize the EU in which, according to him, “something is not right”.
The Hungarian government announced on January 22 that it had reached an agreement to buy “large quantities” of the Russian vaccine Sputnik V, although it has not yet been authorized by European health authorities.
Foreign Minister Peter Szijjarto, visiting Moscow, made the announcement in a video posted to his Facebook account. “Details will be given later,” he said, as reported by AFP.
The announcement comes as the Hungarian regulator gave the green light to the use of the vaccine this week, amid criticism from Budapest of the “slowness” of the vaccine approval process by the European Medicines Agency ( EMA).
Only two vaccines are currently authorized in the UEC: Pfizer-BioNTech and Moderna. The opinion on that of AstraZeneca, already in use in the United Kingdom, is due before the end of the month.
If there is no Union vaccine, let’s take it elsewhere
Prime Minister Viktor Orban reiterated his impatience on Friday, the day after a summit of the Twenty-Seven by video conference on the subject.
Russian authorities have applied for registration in the EU
“We will have to face the fact that something is wrong at EU level,” he lambasted during his traditional weekly radio interview. “If there is no vaccine from the Union, let’s take it elsewhere. It is not possible that the Hungarians die because of that ”, added the leader, customary of the standoff with Brussels.
Russian authorities have applied for EU registration of Sputnik V, which Moscow says is more than 90% effective, but the EMA has not yet started the review process.
“Hungary is the first EU country to realize the benefits of Sputnik V,” Kirill Dmitriev, director of the Russian Sovereign Fund (RDIF), who financed the development of the vaccine, welcomed Thursday in a statement. . Hungary has also ordered one million doses of the Chinese Sinopharm vaccine and is awaiting the green light from Hungarian inspectors, who are currently in Beijing.